Krystal Biotech, Inc. Common Stock (KRYS) Stock Analysis
Price: $353.40 · +0.72%
Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
AnalystsStrong Buy19 analystsWhat's happening with KRYS
Price History
5-Year Weekly Candlestick Chart
Insider Transactions
Recent SEC Form 4 filings
- SellOpen market sale · filed 2026-08-14-40 sh2026-08-14
- SellOpen market sale · filed 2026-08-14-3095 sh2026-08-14
- SellOpen market sale · filed 2026-08-14-4896 sh2026-08-14
- SellOpen market sale · filed 2026-08-14-7428 sh2026-08-14
- SellOpen market sale · filed 2026-08-14-1687 sh2026-08-14
+3 more recent filings
See how KRYS ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all KRYS moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 22 | Regular | 352.84 | +5.69% | 3.30 |
| Sep 22 | After-hours | 353.02 | +5.74% | 3.33 |
Frequently Asked Questions about KRYS
What is the current Krystal Biotech, Inc. Common Stock (KRYS) stock price?
KRYS is trading at $353.40 in pre-market trading, up 0.72% on the session. PreMarketPrice tracks KRYS pre-market, intraday and after-hours prices.
Is KRYS stock overvalued?
Krystal Biotech, Inc. Common Stock trades at a trailing P/E of 51.0. See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Krystal Biotech, Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for KRYS. The Earnings section lists recent reports and updates as dates are announced.
What sector does Krystal Biotech, Inc. Common Stock operate in?
Krystal Biotech, Inc. Common Stock operates in the Healthcare sector, within the Biological Products, (No Diagnostic Substances) industry. The Related Stocks section lists sector peers for comparison.
About Krystal Biotech, Inc. Common Stock (KRYS) Stock
Krystal Biotech, Inc. Common Stock (KRYS) is a US-listed stock operating in the Healthcare sector, specifically the Biological Products, (No Diagnostic Substances) industry. As of the latest update, Krystal Biotech, Inc. Common Stock is trading at $353.40, up 0.72% on the day with a market capitalization of $10.5 billion. The financial health score for KRYS has not yet been calculated — analysis data is being compiled. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for KRYS stock.
KRYS Stock Analysis & Key Metrics
On PreMarketPrice, you can track Krystal Biotech, Inc. Common Stock (KRYS) across multiple dimensions:
- Pre-market price & movement: Real-time KRYS stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Financial health score: A composite score based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for KRYS.
- Sector peers: Compare KRYS against 10 other healthcare stocks on key financial metrics.
Is KRYS a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Krystal Biotech, Inc. Common Stock (KRYS) as an investment. The financial health score is being calculated.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Krystal Biotech, Inc. Common Stock (KRYS) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.